Management reiterated fiscal 2027 net sales guidance of USD 1,535 million to USD 1,560 million and said net sales point to the high end of that range, citing continued strength in the Medical vertical. AdjustedOperating Incomeis guided at 4.4% to 4.7% of net sales, …
The company now places full year Adjusted EBITDA at the high end of USD 1.04 billion to USD 1.1 billion. It also projects 2026 capital expenditures, including maintenance, at about 5% below the August guidance of USD 560 million, which it attributed to execution …
Management attributed the revenue increase to new customers, geographic expansion, expanded platform usage including text messaging and WhatsApp, and new offerings. About 60% of the increase came from new customers and about 40% from existing ones.Gross Profitwas USD 287.38 million, or 74.2% of revenue, …
Chief Executive Officer Jason Long said the company is increasing its full-year guidance based on organic and M&A momentum across its acreage. During the quarter LandBridge acquired approximately 25,000 acres across the Delaware Basin through several transactions, including fee surface and mineral classified surface …
The first agreement carried a non-refundable advance deposit of about USD 7.1 million received in the first quarter, with deliveries starting in the second quarter and USD 21.7 million of related sales recognized through September 30. A second deposit of about USD 8.0 million …
Total revenue was USD 55.5 million, a decrease of 26% from the prior year. Low-enriched uranium segment revenue was USD 31.8 million against USD 44.8 million, with uranium revenue lower on a smallerVolumesold. Separative work unit revenue rose, reflecting a 19% increase in volume …
TheBusinessreports one segment with two activities. CDMORevenuewas USD 17.78 million against USD 21.75 million a year earlier, and hyaluronic acid manufacturing revenue was USD 7.55 million against USD 9.36 million. Within CDMO, the company cited USD 3.7 million of lower salesVolumeand USD 2.3 million …
The company and the Liberty Puerto Rico borrowing group have engaged advisors and are in discussions with creditors about the liabilities tied to the senior secured proceeds loans. As of November 4, 2026, those discussions had not produced an agreement. The company disclosed that …
The purchase closed after the quarter ended, so it is not part of the reported results. Management said the sales are to transition into its own channel over the next 18 to 24 months as B. Braun customer contracts conclude or transfer. During that …
Services revenue was USD 599 million against USD 601 million, and products revenue was USD 225 million against USD 240 million. The company stated total revenue decreased 2%, with nine-month revenue of USD 2.44 billion against USD 2.42 billion.